XML 34 R24.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
March 31, 2025December 31, 2024
Cash and cash equivalents$321,617 $161,435 
Restricted cash6,140 6,137 
Total cash, cash equivalents and restricted cash$327,757 $167,572 
Schedule of Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
March 31, 2025December 31, 2024
Cash and cash equivalents$321,617 $161,435 
Restricted cash6,140 6,137 
Total cash, cash equivalents and restricted cash$327,757 $167,572 
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net loss per share (in thousands, except shares and per share data):
Three Months Ended
March 31,
20252024
Net income (loss) from continuing operations$188,488 $(56,329)
Less: net loss attributable to non-controlling interest574 
Net income (loss) from continuing operations available to common shareholders
188,493 (55,755)
Net loss from discontinued operations, net of tax
— (255)
Net income (loss) attributable to common shareholders
$188,493 $(56,010)
Shares used in computation:
Weighted-average common shares outstanding
Basic341,059,213 299,363,298 
Diluted341,564,506 299,363,298 
Net income (loss) per share - basic
Continuing operations$0.55 $(0.19)
Discontinued operations$— $— 
Total net income (loss) per share - basic$0.55 $(0.19)
Net income (loss) per share - diluted
Continuing operations$0.55 $(0.19)
Discontinued operations$— $— 
Total net income (loss) per share - diluted$0.55 $(0.19)
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share
The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:
March 31,
20252024
Warrants to purchase common stock166,667 166,670 
Stock options15,282,185 18,932,300 
Unvested restricted stock units33,591,214 21,971,649 
Convertible notes variable settlement feature48,771,938 49,583,637 
Total97,812,004 90,654,256